Rod phototransduction in transgenic mice expressing a mutant opsin gene

Journal of the Optical Society of America A: Optics and Image Science, and Vision

Volumn 13, Issue 3, 1996, Pages 577-585

  Goto, Yoshinobu ^a   Peachey, Neal S ^a   Ziroli, Nancy E ^b   Seiple, William H ^c   Gryczan, Chester ^d   Pepperberg, David R ^d   Naash, Muna I ^d  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPSIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; ELECTRORETINOGRAPHY; GENE EXPRESSION REGULATION; GENETICS; LIGHT; MOUSE; MUTATION; PHYSIOLOGY; REFERENCE VALUE; RETINA ROD; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; ELECTRORETINOGRAPHY; GENE EXPRESSION REGULATION; LIGHT; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MUTATION; OPSIN; REFERENCE VALUES; RODS (RETINA); SIGNAL TRANSDUCTION;

EID: 0030098178     PISSN: 10847529     EISSN: 15208532     Source Type: Journal    
DOI: 10.1364/JOSAA.13.000577     Document Type: Article

References (48)

1. H. G. Khorana, “Rhodopsin, photoreceptor of the rod cell,” J. Biol. Chem. 267, 1–4 (1992).
2. L. Stryer, “Molecular basis of visual excitation,” Cold Spring Harbor Symp. Quant. Biol. 53, 283–294 (1988).
3. T. P. Dryja, T. L. McGee, E. Reichel, L. B. Hahn, G. S. Cowley, D. W. Yandell, M. A. Sandberg, and E. L. Berson, “A point mutation of the rhodopsin gene in one form of retinitis pigmentosa,” Nature (London) 343, 364–369 (1990).
4. T. P. Dryja, L. B. Hahn, G. S. Cowley, T. L. McGee, and E. L. Berson, “Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa,” Proc. Natl. Acad. Sci. (USA) 88, 9370–9374 (1991).
5. C.-H. Sung, C. M. Davenport, J. C. Hennessey, I. H. Maume-nee, S. G. Jacobson, J. R. Heckenlively, R. Nowakowski, G. A. Fishman, P. Gouras, and J. Nathans, “Rhodopsin mutations in autosomal dominant retinitis pigmentosa,” Proc. Natl. Acad. Sci. (USA) 88, 6481–6485 (1991).
6. E. L. Berson, “Retinitis pigmentosa,” Invest. Ophthalmol. Vis. Sci. 34, 1659–1676 (1993).
7. J. R. Heckenlively, Retinitis Pigmentosa (Lippincott, Philadelphia, Pa., 1988).
8. C. E. Keeler, “The inheritance of a retinal abnormality in white mice,” Proc. Natl. Acad. Sci. (USA) 10,329-333 (1924).
9. R. Van Nie, D. Ivanyi, and P. Dement, “A new H-2 linked mutation, rds, causing retinal degeneration in the mouse,” Tissue Antigens 12, 106–108 (1978).
10. J. E. Olsson, J. W. Gordon, B. S. Pawlyk, D. Roof, A. Hayes, R. S. Molday, S. Mukai, G. S. Cowley, E. L. Berson, and T. P. Dryja, “Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa,” Neuron 9, 815–830 (1992).
11. J. Chen, B. Woodford, H. Jiang, T. Nakayama, and M. I. Simon, “Expression of a C-terminal truncated rhodopsin gene leads to retinal degeneration in transgenic mice,” Invest. Ophthalmol. Vis. Sci. 34, 768 (1993).
12. M. I. Naash, J. G. Hollyfield, M. R. Al-Ubaidi, and W. Baehr, “Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene,” Proc. Natl. Acad. Sci. (USA) 90, 5499–5503 (1993).
13. M. I. Naash, M. R. Al-Ubaidi, J. G. Hollyfield, and W. Baehr, “Simulation of autosomal dominant retinitis pigmentosa in transgenic mice,” in Retinal Degenerations: Clinical and Laboratory Applications, R. E. Anderson, J. G. Holly-field, and M. M. LaVail, eds. (Plenum, New York, 1993), pp. 201–210.
14. F. Wong, “Creating transgenic mouse models of photoreceptor degeneration caused by mutations in the rhodopsin gene,” in Retinal Degenerations: Clinical and Laboratory Applications, R. E. Anderson, J. G. Hollyfield, and M. M. LaVail, eds. (Plenum, New York, 1993), pp. 211–217.
15. C.-H. Sung, C. L. Makino, D. A. Baylor, and J. Nathans, “A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment,” J. Neurosci. 14, 5818–5833 (1994).
16. J. Chen, C. L. Makino, N. S. Peachey, D. A. Baylor, and M. I. Simon, “Mechanisms of rhodopsin inactivation in vivo as revealed by a COOH-terminal truncation mutant,” Science 267, 374–377 (1995).
17. C. W. Gryczan, J. R. Kuszak, L. Novak, N. S. Peachey, Y. Goto, and M. I. Naash, “A transgenic mouse model for autosomal dominant retinitis pigmentosa caused by a three base pair deletion in codon 255/256 of the opsin gene,” Invest. Ophthalmol. Vis. Sci. 36, S423 (1995).
18. M. A. Sandberg, B. S. Pawlyk, W. K. Franson, T. P. Dryja, and E. L. Berson, “Effect of light on the rate of ERG decline in transgenic mice with the human rhodopsin mutation pro23his,” Invest. Ophthalmol. Vis. Sci. 34, 1078 (1993).
19. M. I. Naash, Y. Goto, C. Gryczan, N. S. Peachey, A. H. Milam, Z.-Y. Li, and H. Ripps, “Light-deprivation retards photoreceptor cell death in transgenic mice expressing mutant opsin,” Invest. Ophthalmol. Vis. Sci. 36, S638 (1995).
20. Y. Goto, N. S. Peachey, H. Ripps, and M. I. Naash, “Functional abnormalities in transgenic mice expressing a mutant rhodopsin gene,” Invest. Ophthalmol. Vis. Sci. 36, 62–71 (1995).
21. T. Cheng and M. I. Naash, “Quantitative analysis of mRNA levels of the transgenic and endogenous opsin genes in retinas of transgenic mice,” Invest. Ophthalmol. Vis. Sci. 36, S273 (1995).
22. C. M. Kemp, S. G. Jacobson, A. J. Roman, C.-H. Sung, and J. Nathans, “Abnormal rod dark adaptation in autosomal dominant retinitis pigmentosa with proline-23-histidine rhodopsin mutation,” Am. J. Ophthalmol. 113, 165–174
23. R. D. Penn and W. A. Hagins, “Signal transmission along retinal rods and the origin of the electroretinographic a-wave,” Nature (London) 233, 201–205 (1969).
24. R. D. Penn and W. A. Hagins, “Kinetics of the photocurrent of retinal rods,” Biophys. J. 12, 1073–1094 (1972).
25. D. C. Hood and D. G. Birch, “A quantitative measure of the electrical activity of human rod photoreceptors using electroretinography,” Vis. Neurosci. 5, 379–387 (1990).
26. M. E. Breton, A. W. Schueller, T. D. Lamb, and E. N. Pugh Jr., “Analysis of ERG a-wave amplification and kinetics in terms of the G-protein cascade of phototransduction,” Invest. Ophthalmol. Vis. Sci. 35, 295–309 (1994).
27. D. C. Hood and D. G. Birch, “Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave,” Invest. Ophthalmol. Vis. Sci. 35, 2948–2961 (1994).
28. D. C. Hood and D. G. Birch, “Light adaptation of human rod receptors: the leading edge of the human a-wave and models of rod receptor activity,” Vision Res. 33, 1605–1618 (1993).
29. S. G. Jacobson, C. M. Kemp, A. V. Cideciyan, J. P. Macke, C. Sung, and J. Nathans, “Phenotypes of stop codon and splice site rhodopsin mutations causing retinitis pigmentosa,” Invest. Ophthalmol. Vis. Sci. 35, 2521–2534 (1994).
30. M. E. Breton, G. E. Quinn, and A. W. Schueller, “Development of ERG and rod phototransduction response in human infants,” Invest. Ophthalmol. Vis. Sci. 36, 1588–1602 (1995).
31. D. G. Birch, D. C. Hood, S. Nusinowitz, and D. R. Pepper-berg, “Abnormal activation and inactivation mechanisms of rod transduction in patients with autosomol dominant retinitis pigmentosa and the pro-23-his mutation,” Invest. Ophthalmol. Vis. Sci. 36, 1603–1614 (1995).
32. S. Shady, D. C. Hood, and D. G. Birch, “Rod phototransduction in retinitis pigmentosa. Distinguishing alternative mechanisms of degeneration,” Invest. Ophthalmol. Vis. Sci. 36, 1027–1037 (1995).
33. T. D. Lamb and E. N. Pugh Jr., “A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors,” J. Physiol. (London) 499, 719–758 (1992).
34. E. N. Pugh Jr., and T. D. Lamb, “Amplification and kinetics of the activation steps in phototransduction,” Biochim. Biophys. Acta 1141,111-149 (1993).
35. R. Granit, “The components of the retinal action potential in mammals and their relation to the discharge in the optic nerve,” J. Physiol. (London) 77, 207–239 (1933).
36. C. A. Curcio, K. R. Sloan, R. E. Kalina, and A. E. Hendrickson, “Human photoreceptor topography,” J. Comp. Neurol. 292, 497–523 (1990).
37. L. D. Carter-Dawson and M. M. LaVail, “Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopy,” J. Comp. Neurol. 188,245-262 (1979).
38. G. H. Jacobs, J. Neitz, and J. F. Deegan II, “Retinal receptors in rodents maximally sensitive to ultraviolet light,” Nature (London) 353, 655–656 (1991).
39. D. C. Hood and D. G. Birch, “Human cone receptor activity: the leading edge of the a-wave and models of receptor activity,” Vis. Neurosci. 10, 857–871 (1993).
40. N. S. Peachey, Y. Goto, A. B. Quiambao, and M. R. Al-Ubaidi, “Functional consequences of oncogene expression in photoreceptors of transgenic mice,” Vis. Neurosci. 12, 513–522 (1995).
41. T. Benzschawel and R. W. Massof, “Psychophysical studies of rod response kinetics in retinitis pigmentosa,” Clin. Vision Sci. 1, 119–136 (1986).
42. T. D. Ting, T.-H. Wu, T.-I. L. Okajima, D. R. Pepperberg, and M. I. Naash, “Analysis of rhodopsin and retinoids in a transgenic mouse model of ADRP,” Invest. Ophthalmol. Vis. Sci. 36, S5 (1995).
43. A. Hughes, “A schematic eye for the rat,” Vision Res. 19, 569–588 (1979).
44. S. Remtulla and P. E. Hallett, “A schematic eye for the mouse, and comparisons with the rat,” Vision Res. 25, 21–31 (1985).
45. D. R. Pepperberg, M. C. Cornwall, M. Kahlert, K. P. Hofmann, J. Jin and G. J. Jones, and H. Ripps, “Light-dependent delay in the falling phase of the retinal rod photoresponse,” Vis. Neurosci. 8, 9–18 (1992).
46. D. R. Pepperberg, J. Jin, and G. J. Jones, “Modulation of transduction gain in light adaptation of retinal rods,” Vis. Neurosci. 11, 53–62 (1994).
47. D. W. Corson, M. C. Cornwall, and D. R. Pepperberg, “Evidence for the prolonged photoactivated lifetime of an analogue visual pigment containing 11-cis 9-desmethylretinal,” Vis. Neurosci. 11,91-98 (1994).
48. D. G. Birch, W. Kedzierski, S. Nusinowitz, J. L. Anderson, and G. H. Travis, “Rod photoreceptor function in transgenic mice expressing mutant rds/peripherin,” Invest. Ophthalmol. Vis. Sci. 36, S641 (1995).